Adherence to clinical trial registration in countries of Latin America and the Caribbean, 2015

Abstract

Objective To determine the prevalence of clinical trial registration in the International Clinical Trial Registry Platform (ICTRP) for studies from Latin America and the Caribbean (LAC) and to identify the key characteristics that lead to prospective and retrospective registration. Methods A cross-sectional study identified published, clinical trial studies through a search of PubMed, LILACS (Latin American and Caribbean Center on Health Sciences Information), and the Cochrane Central Register of Controlled Trials. Studies were included if published on 1 January – 31 December 2015, at least one author was affiliated with at least one LAC country, the clinical trial was conducted in at least one LAC site, and the full text of the article was available. A manual search of reference lists was also conducted. ICTRP registration information and key trial characteristics were compared. Results Of 1 502 CT references that met inclusion criteria, 297 were randomly-selected, 90.9% of which were published in English, 65% from Brazil, and 76.8% had a LAC author as the first author. The proportion of CT registered in the ICTRP was 59.9 %, of which 51.7% were registered prospectively. Clinicaltrials.gov was most frequently used registry (84.8%), followed by the Registro Brasileiro de Ensaios Clínicos and the Registro Público Cubano de Ensayos Clínicos . Key characteristics that favored registration were being in study phase 3 or 4 or being a multi-center study. Data was compared to a similar study from 2013 that reported a registration rate of only 19.8%. Conclusions Registration adherence and prospective registration have increased in LAC in recent years, but the proportion of unregistered CT remains high. While there are still many challenges to overcome, the adherence strategies implemented in recent years have proven effective.

El panorama de los ensayos clínicos sobre COVID-19 en América Latina y el Caribe: evaluación y desafíos

“…Los países deben exigir la inclusión de todos los ensayos clínicos en registros que son parte de la ICTRP. Actualmente, algunos países de la Región carecen de un mecanismo para registrar los ensayos clínicos, y algunos tienen registros nacionales que no están disponibles públicamente o que no forman parte de la ICTRP ( 6 ). De igual forma, es fundamental que la ICTRP funcione de manera óptima.…”

Cross-Sectional Survey of Clinical Trials of Stem Cell Therapy for Heart Disease Registered at ClinicalTrials.gov

“…Most trials were also performed in continents with a high GDP; one-third of clinical trials were conducted in each of Europe and North America. The high proportion of trials from Europe and North America may also reflect the fact that ClinicalTrials.gov is an American database, whereas other platforms are also used (19)(20)(21). The most common start date was 2007, followed by 2006-2010, and 2011-2015.…”

The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges

“…Countries must therefore require the registration of all clinical trials in registries that feed into ICTRP. Currently, some LAC countries lack a mechanism to register clinical trials and some have national clinical trials registries that are not publicly available or do not feed into ICTRP ( 6 ). It is also crucial for ICTRP to function optimally.…”